{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:13:09Z","timestamp":1761293589272,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.metabol.2017.06.004","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T06:03:42Z","timestamp":1497938622000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density"],"prefix":"10.1016","volume":"74","author":[{"given":"Thomas J.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce A.","family":"Hogue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall P.","family":"Scheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanziana A.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Sosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2017.06.004_bb0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1359\/JBMR.050910","article-title":"Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993\u20132001: an update on the changing epidemiology of the disease","volume":"21","author":"Wermers","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.06.004_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4158\/EP.11.1.49","article-title":"The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism","volume":"11","author":"AACE\/AAES Task Force on Primary Hyperparathyroidism","year":"2005","journal-title":"Endocr Pract"},{"key":"10.1016\/j.metabol.2017.06.004_bb0015","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jc.2009-2819","article-title":"Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism","volume":"95","author":"Wu","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.06.004_bb0020","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1634\/theoncologist.2010-0158","article-title":"Parathyroid surgery in the elderly","volume":"15","author":"Morris","year":"2010","journal-title":"Oncologist"},{"key":"10.1016\/j.metabol.2017.06.004_bb0025","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMcp032200","article-title":"Clinical practice. Asymptomatic primary hyperparathyroidism","volume":"350","author":"Bilezikian","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2017.06.004_bb0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2265.2007.03109.x","article-title":"Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism","volume":"68","author":"Moosgaard","year":"2008","journal-title":"Clin Endocrinol"},{"issue":"Suppl. 2","key":"10.1016\/j.metabol.2017.06.004_bb0035","first-page":"N24","article-title":"The pathophysiology of primary hyperparathyroidism","volume":"17","author":"Brown","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.06.004_bb0040","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.5858\/2008-132-1251-PHACP","article-title":"Primary hyperparathyroidism: a current perspective","volume":"132","author":"DeLellis","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"10.1016\/j.metabol.2017.06.004_bb0045","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/jclinpath-2015-203186","article-title":"Clinicopathological correlates of hyperparathyroidism","volume":"68","author":"Duan","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.metabol.2017.06.004_bb0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/archsurg.143.3.260","article-title":"The changing presentation of hyperparathyroidism over 3 decades","volume":"143","author":"Mazzaglia","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.metabol.2017.06.004_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0022-3859.97171","article-title":"Influence of age and gender on presentation of symptomatic primary hyperparathyroidism","volume":"58","author":"Shah","year":"2012","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.metabol.2017.06.004_bb0060","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00423-010-0675-5","article-title":"Changing biochemical presentation of primary hyperparathyroidism","volume":"395","author":"Almquist","year":"2010","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.metabol.2017.06.004_bb0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00423-006-0097-6","article-title":"Scandinavian quality register for thyroid and parathyroid surgery: audit of surgery for primary hyperparathyroidism","volume":"392","author":"Bergenfelz","year":"2007","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.metabol.2017.06.004_bb0070","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.surg.2003.06.001","article-title":"Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?","volume":"134","author":"Carneiro","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.metabol.2017.06.004_bb0075","doi-asserted-by":"crossref","first-page":"e0161134","DOI":"10.1371\/journal.pone.0161134","article-title":"A novel ex vivo method for visualizing live-cell calcium response behavior in intact human tumors","volume":"11","author":"Koh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2017.06.004_bb0080","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jcmm.12732","article-title":"Single-cell functional analysis of parathyroid adenomas reveals distinct classes of calcium sensing behaviour in primary hyperparathyroidism","volume":"20","author":"Koh","year":"2016","journal-title":"J Cell Mol Med"},{"year":"2011","series-title":"Data mining: concepts and techniques","author":"Han","key":"10.1016\/j.metabol.2017.06.004_bb0090"},{"key":"10.1016\/j.metabol.2017.06.004_bb0095","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1214\/aos\/1176350366","article-title":"High breakdown-point and high efficiency robust estimates for regression","volume":"15","author":"Yohai","year":"1987","journal-title":"Ann Stat"},{"key":"10.1016\/j.metabol.2017.06.004_bb0100","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2017.06.004_bb0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ng.2492","article-title":"Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3","volume":"45","author":"Nesbit","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2017.06.004_bb0110","series-title":"Molecular pathology of endocrine diseases","first-page":"139","article-title":"Clinical detection and treatment of parathyroid diseases","author":"Stang","year":"2010"},{"key":"10.1016\/j.metabol.2017.06.004_bb0115","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/archsurg.141.9.885","article-title":"The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism","volume":"141","author":"VanderWalde","year":"2006","journal-title":"Arch Surg"},{"key":"10.1016\/j.metabol.2017.06.004_bb0120","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S8756-3282(99)00208-2","article-title":"Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study","volume":"25","author":"Christiansen","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.06.004_bb0125","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.surg.2012.08.015","article-title":"Changes in bone mineral density after surgical intervention for primary hyperparathyroidism","volume":"152","author":"Dy","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/j.metabol.2017.06.004_bb0130","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1210\/jc.2013-1518","article-title":"Bone mineral density evolution after successful parathyroidectomy in patients with normocalcemic primary hyperparathyroidism","volume":"98","author":"Koumakis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.06.004_bb0135","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00268-014-2555-6","article-title":"Predictors of bone mineral density improvement in patients undergoing parathyroidectomy for primary hyperparathyroidism","volume":"38","author":"Sharma","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.metabol.2017.06.004_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(99)00150-7","article-title":"Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy","volume":"25","author":"Christiansen","year":"1999","journal-title":"Bone"},{"key":"10.1016\/j.metabol.2017.06.004_bb0145","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1111\/jgs.12968","article-title":"Surgical management of primary hyperparathyroidism in older adults","volume":"62","author":"Denizot","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.metabol.2017.06.004_bb0150","first-page":"35","article-title":"Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism","volume":"70","author":"Jacobs","year":"2012","journal-title":"Neth J Med"},{"key":"10.1016\/j.metabol.2017.06.004_bb0155","first-page":"jc20141417","article-title":"Medical management of primary hyperparathyroidism: proceedings of the fourth international workshop on the management of asymptomatic primary hyperparathyroidism","author":"Marcocci","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.06.004_bb0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1507\/endocrj.47.231","article-title":"Evaluation of changes in bone density and biochemical parameters after parathyroidectomy in primary hyperparathyroidism","volume":"47","author":"Nakaoka","year":"2000","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2017.06.004_bb0165","first-page":"1901","article-title":"Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism","volume":"85","author":"Nakaoka","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.06.004_bb0170","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial. FIT research group","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2017.06.004_bb0175","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1053\/ajkd.2002.31402","article-title":"Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure","volume":"39","author":"Kazama","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.metabol.2017.06.004_bb0180","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","article-title":"Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure","volume":"58","author":"Picton","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.metabol.2017.06.004_bb0185","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1359\/jbmr.2002.17.9.1667","article-title":"Cyclic adenosine monophosphate\/protein kinase A mediates parathyroid hormone\/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells","volume":"17","author":"Kondo","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.06.004_bb0190","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jcp.24790","article-title":"The cooperation of CREB and NFAT is required for PTHrP-induced RANKL expression in mouse osteoblastic cells","volume":"230","author":"Park","year":"2015","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2017.06.004_bb0195","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00439-006-0155-8","article-title":"A functional polymorphism in the PTHR1 promoter region is associated with adult height and BMD measured at the femoral neck in a large cohort of young caucasian women","volume":"119","author":"Scillitani","year":"2006","journal-title":"Hum Genet"},{"key":"10.1016\/j.metabol.2017.06.004_bb0200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00223-007-9072-7","article-title":"PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton","volume":"81","author":"Vilarino-Guell","year":"2007","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.metabol.2017.06.004_bb0205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.metabol.2017.06.004_bb0210","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrendo.2015.71","article-title":"Short-term and long-term effects of osteoporosis therapies","volume":"11","author":"Reid","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2017.06.004_bb0215","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1210\/jc.2009-2384","article-title":"Skeletal effects of interventions in mild primary hyperparathyroidism: a meta-analysis","volume":"95","author":"Sankaran","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517301610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049517301610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:14:14Z","timestamp":1758428054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049517301610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"alternative-id":["S0026049517301610"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2017.06.004","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2017.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}